We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Solicitor General to High Court: Review Case on Biosimilar Launch Delays
The item has been added to your shopping cart.
Solicitor General to High Court: Review Case on Biosimilar Launch Delays
The U.S. solicitor general has urged the Supreme Court to review a Federal Circuit decision that requires some biosimilar makers wait six months after receiving FDA approval to launch a product.